NCT04481412View on ClinicalTrials.gov

Topical Cetirizine in Androgenetic Alopecia in Females

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 25, 2020

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2021

Conditions
Androgenetic Alopecia
Interventions
DRUG

Topical cetirizine

Topical cetirizine 1% spray that will be prepared at Faculty of Pharmacy, Cairo University and will be applied once daily.

DRUG

Placebo

96% ethanol that will be applied once daily.

DRUG

Topical minoxidil

Topical Minoxidil 5% that will be applied once daily.

Trial Locations (1)

11559

Al-Kasr Al-Ainy outpatient dermatology clinic, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT04481412 - Topical Cetirizine in Androgenetic Alopecia in Females | Biotech Hunter | Biotech Hunter